Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The bare lymphocyte syndrome.

J L Touraine1, G L Marseglia, H Betuel

  • 1Department of Transplantation and Clinical Immunology, Claude Bernard University, Lyon, France.

Bone Marrow Transplantation
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional disparities in access to epinephrine auto-injectors for children and adults in Italy.

European annals of allergy and clinical immunology·2026
Same author

Allergic rhinitis management: a survey on Italian primary care pediatricians.

European annals of allergy and clinical immunology·2024
Same author

A low-dose multicomponent medication as a new approach in prevention and early add-on treatment of recurrent respiratory infections in children: a Delphi Consensus.

European review for medical and pharmacological sciences·2024
Same author

Evaluation of two different remineralising toothpastes in children with drug-controlled asthma and allergic rhinitis: a randomised clinical trial.

European journal of paediatric dentistry·2024
Same author

Impact of individual molecular components in determining primary sensitization to latex.

Immunobiology·2023
Same author

The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview.

Italian journal of pediatrics·2022
Same journal

CHIME: a novel HLA eplet model associates with non-relapse mortality in haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.

Bone marrow transplantation·2026
Same journal

Transplant outcomes for patients with severe acquired aplastic anemia over the age of 40 using busulfan, fludarabine, reduced-dose cyclophosphamide, and anti-thymocyte globulin conditioning regimen.

Bone marrow transplantation·2026
Same journal

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same journal

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
See all related articles

Bare lymphocyte syndrome is a severe combined immunodeficiency due to absent HLA antigens, causing recurrent infections. Current treatments focus on fetal stem cell transplants, with gene therapy as a future possibility.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Bare lymphocyte syndrome (BLS) is a primary immunodeficiency characterized by absent human leukocyte antigen (HLA) expression.
  • This deficiency affects both class I and class II HLA molecules, leading to severe immune system impairment.

Purpose of the Study:

  • To describe the clinical manifestations and immunological characteristics of bare lymphocyte syndrome.
  • To review current and potential future therapeutic strategies for BLS.

Main Methods:

  • Clinical case review and immunological assessment of patients with BLS.
  • Literature review of genetic defects and treatment outcomes for BLS.

Main Results:

  • BLS presents with recurrent respiratory and digestive tract infections.

Related Experiment Videos

  • Affected individuals exhibit absent antibody formation and impaired cell-mediated immunity to specific antigens, despite normal transplant immunity.
  • Genetic defects are not located on chromosome 6.

    • Conclusions:

    • Bare lymphocyte syndrome is a critical combined immunodeficiency with significant morbidity.
    • In utero stem cell transplantation is the current optimal treatment.
    • Gene therapy holds promise for future treatment of BLS.